Delivery Order SPE2DB20D1109-SPE2DB25FP09L
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $22,802.68 and a period of performance through January 7, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,317.92, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. This is a firm fixed-price delivery order contract with an ultimate completion date of December 27, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
This federal contract award, with a ceiling value of $3,353.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a period of performance through July 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $10,917.12 to provide CATHFLO ACTIVASE 2 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that runs through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,679.87 delivery order contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The award is not set aside and is a firm fixed-price contract type with a performance period ending on May 15, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of CATHFLO ACTIVASE 2 MG VIALS to the Department of Defense (DoD) and its affiliated agencies. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a supplier of a wide range of medical products to the federal government. The contract, valued at $5,618.78, is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $3,393.60 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a period of performance through January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This federal contract award, valued at $9,796.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CATHFLO ACTIVASE 2 MG VIALS, with a completion date of November 15, 2024. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award is for the delivery of ACTIVASE 50 MG VIALS to the Defense Logistics Agency (DLA). The $24,396.80 firm-fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024, with a completion date of November 15, 2024. This contract is a delivery order under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, valued at $5,429.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 16, 2025. The contract is for the procurement of CATHFLO ACTIVASE 2 MG VIALS, a critical medical commodity supporting the healthcare needs of military personnel, veterans, and other...